Clinical Trial Update: Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a mepolizumab-based regimen versus conventional therapy in eosinophilic granulomatosis with polyangiitis; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Eosinophilic Granulomatosis With Polyangiitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING